Structure-based drug discovery of novel fused-pyrazolone carboxamide derivatives as potent and selective AXL inhibitors

Acta Pharmaceutica Sinica B - Tập 13 - Trang 4918-4933 - 2023
Feifei Fang1, Yang Dai2, Hao Wang3,4, Yinchun Ji2, Xuewu Liang2,4, Xia Peng2, Jiyuan Li2, Yangrong Zhao2, Chunpu Li2,4, Danyi Wang2,4, Yazhou Li2, Dong Zhang2, Dan Zhang2, Meiyu Geng2,4,5,6, Hong Liu2,4,6, Jing Ai2,4,6, Yu Zhou3,4,6
1Lingang Laboratory, Shanghai 200031, China
2State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
3Drug Discovery & Development Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
4University of Chinese Academy of Sciences, Beijing, 100049, China
5Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai, 264117, China
6School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, UCAS, Hangzhou 310024, China

Thông tin
Thông tin xuất bản

Acta Pharmaceutica Sinica B

Tập 13

4918-4933

Thông tin tác giả